High-quality Compounded Medications From a 503B Facility

ImprimisRx is dedicated to delivering high-quality and innovative compounded medications at affordable prices. They have a 503B FDA-registered outsourcing facility that is inspected by the FDA and the bulk active and inactive substances are obtained from FDA-registered manufacturers, accompanied by a certificate of analysis. Sterility and potency testing is performed on each batch at FDA-registered labs. Available formulations include compounded injectables such as Tri-Moxi, Moxifloxacin, Hyaluronidase, Lidocaine, etc., combination steroid, antibiotic, NSAID, and patented MKO (Midazolam/Ketamine/Ondansetron) Melt.

For more information, call (844) 446-6979, visit www.order.imprimisrx.com or click on "Learn More" below.